A randomized controlled study on the treatment of ulcerative colitis with fatigue in patients with spleen deficiency and damp-heat type by Jianpi-Qingchang decoction

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Test group:Jianpi‐Qingchang decoction+Mesalazine;Control group:Mesalazine ; CONDITION: ulcerative colitis PRIMARY OUTCOME: Fatigue Scale,FS‐14;Disease activity index; SECONDARY OUTCOME: Inflammatory Bowel Disease Questionnaire, IBDQ;Evaluation criteria for curative effect of TCM symptoms; INCLUSION CRITERIA: (1) Age 18‐70 years, both sexes. (2) All patients were diagnosed with ulcerative colitis by e‐colonoscopy and pathology, and the diagnosis was in accordance with the criteria established in the Consensus Opinion on the Diagnosis and Treatment of Inflammatory Bowel Disease (Beijing, 2018) . (3) Meet the criteria for the identification of spleen deficiency and damp‐heat evidence in Chinese medicine in the 2018 Guidelines for the Treatment of Ulcerative Colitis, a Common Disease of the Digestive System . (4) Have had a colonoscopy within the last 1 year. (5) No serious heart, liver, kidney or other important organ and hematologic disorders. (6) The patient fully understands the purpose and content of the test, has good compliance, and voluntarily signs the informed consent form.
Epistemonikos ID: a3f75c8389ee0bec73a572520919d8d55d42a4d0
First added on: Feb 20, 2024